Ofatumumab With Fludarabine and Cyclophosphamide in B-CLL Patients

Clinical trial NCT00410163 · COMPLETED

Trial details

NCT number: NCT00410163
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Leukaemia, Lymphocytic, Chronic

Start date: 2007-01-01
Primary completion: 2009-03-01
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.